Feedback / Questions
Oclaiz (octreotide subcutaneous depot) - Camurus
https://www.prnewswire.com/news-releases/camurus-announces-fda-acceptance-of-nda-resubmission-for-oclaiz-for-the-treatment-of-acromegaly-302657390.html#:~:text=The%20FDA%20has%20assigned%20a,%2C%20President%20%26%20CEO%2C%20Camurus.
Jan 9, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next